RECRUITINGOBSERVATIONAL
To Perform a Post-market Study of the Performance of the Idylla ThyroidPrint Assay Using Clinical Samples in Predicting the Nature of Indeterminate Thyroid Nodules (ITNs) Across Multiple Centers.
Idylla™ ThyroidPrint® RUO Assay Beta-Trial Study
About This Trial
To perform a post-market study of the performance of the Idylla™ ThyroidPrint® Assay using clinical samples in predicting the nature of indeterminate thyroid nodules (ITNs) across multiple centers.
Who May Be Eligible (Plain English)
Who May Qualify:
- Thyroid nodule ≥1.0 cm
- With indeterminate cytology
- Surgery due to be performed
Who Should NOT Join This Trial:
- Specimens which fail to meet the inclusion criteria.
- FNA fixed in formalin or transferred in alcohol-based collection buffers which is not according to the protocol instructions.
- RNA extracts.
- Patients with ultrasound evidence of malignant cervical adenopathy
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Thyroid nodule ≥1.0 cm
* With indeterminate cytology
* Surgery due to be performed
Exclusion Criteria:
* Specimens which fail to meet the inclusion criteria.
* FNA fixed in formalin or transferred in alcohol-based collection buffers which is not according to the protocol instructions.
* RNA extracts.
* Patients with ultrasound evidence of malignant cervical adenopathy
Locations (1)
Royal Cornwall Hospital
Truro, Cornwall, United Kingdom